Live Breaking News & Updates on Morphosys Conference Call
Stay updated with breaking news from Morphosys conference call. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of MorphoSys AG (NASDAQ:MOR – Get Free Report) traded down 6% during trading on Tuesday . The stock traded as low as $15.97 and last traded at $16.23. 17,579,874 shares were traded during trading, an increase of 527% from the average session volume of 2,805,517 shares. The stock had previously closed at $17.27. Analyst […] ....
Novartis’s €2.7B acquisition of MorphoSys brings two cancer drug candidates, one of which would give the pharmaceutical giant a way to stand apart from other myelofibrosis treatments. In a separate deal, MorphoSys sold to Incyte its rights to a partnered blood cancer drug. ....
MorphoSys AG (NASDAQ:MOR – Free Report) – Leerink Partnrs issued their Q1 2024 earnings estimates for MorphoSys in a report released on Tuesday, January 30th. Leerink Partnrs analyst A. Berens anticipates that the company will post earnings per share of ($0.65) for the quarter. Leerink Partnrs currently has a “Market Perform” rating on the stock. […] ....
EQSAdhoc MorphoSys AG Key word Forecast Ad hoc MorphoSys AG Reports Preliminary 2023 Monjuvi US Net Product Sales and Gross Margin Provides 2024 Financial Guidance and Reduces Financial Liability 30J ....
MorphoSys AG (NASDAQ:MOR – Get Free Report)’s share price gapped up prior to trading on Wednesday . The stock had previously closed at $9.12, but opened at $9.63. MorphoSys shares last traded at $9.66, with a volume of 80,068 shares changing hands. Analysts Set New Price Targets A number of brokerages have recently issued reports […] ....